MedPath

Evaluation of the Clinical Efficacy and Safety of Amlodipine 5mg/ Bisoprolol Fumarate 5mg /Perindopril Arginine 5mg Fixed-dose Combination in Capsule and Free Monotherapy at the Same Dose in Patients With Uncontrolled Essential Hypertension.

Phase 3
Completed
Conditions
Essential Hypertension
Interventions
Combination Product: Amlodipine 5mg + bisoprolol fumarate 5mg + perindopril arginine 5mg
Registration Number
NCT05288400
Lead Sponsor
Servier
Brief Summary

The purpose of this study was to evaluate the efficacy and the safety of a fixed-dose combination in capsule of Amlodipine 5mg/ Bisoprolol fumarate 5mg/ Perindopril arginine 5mg, and free monotherapy at the same dose in patients with uncontrolled essential hypertension.

Detailed Description

This was a phase III, multicenter, randomized, open-label, controlled study, over a 12-week treatment period with a single-capsule of fixed dose combination (FDC) of Amlodipine 5 mg/ Bisoprolol fumarate 5 mg / Perindopril arginine 5 mg and free monocomponents of Amlodipine 5 mg, Bisoprolol fumarate 5 mg and Perindopril arginine 5 mg given concomitantly, in 150 patients with uncontrolled essential HT.

Patients without any non-selection criteria, already treated by anti-hypertensive monotherapy at maximal dose or either by a dual therapy at minimum dose, other than study treatment, having an uncontrolled HT defined by SBP (Systolic Blood Pressure) ≥ 140 and \<160 mmHg and DBP (Diastolic Blood Pressure) ≥ 90 and \<100 mmHg (in supine position) at 2 different visits (selection and inclusion) were to be selected in this study and randomized to one of two treatment groups: single-capsule combination or free therapy without any wash-out period.

For all patients, controlled blood pressure (BP) was defined as SBP \< 140 mmHg and DBP \< 90 mmHg.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group AAmlodipine 5mg + bisoprolol fumarate 5mg + perindopril arginine 5mgsingle-capsule of fixed dosed combination (FDC) of amlodipine 5 mg / bisoprolol fumarate 5 mg / perindopril arginine 5 mg
Group BNorvasc 5mg tabletFree triple therapy of amlodipine 5 mg + bisoprolol fumarate 5 mg + perindopril arginine 5 mg, given concomitantly
Group BConcor 5mg tabletFree triple therapy of amlodipine 5 mg + bisoprolol fumarate 5 mg + perindopril arginine 5 mg, given concomitantly
Group BCoversyl 5mg tabletFree triple therapy of amlodipine 5 mg + bisoprolol fumarate 5 mg + perindopril arginine 5 mg, given concomitantly
Primary Outcome Measures
NameTimeMethod
Change from baseline of blood pressure (SBP and DBP)at baseline, 4, 8 and 12 weeks
Secondary Outcome Measures
NameTimeMethod
Assessment of patient treatment satisfaction TSQM-9 questionnaire12 weeks
Blood pressure control rate (SBP < 140 mmHg and DBP < 90 mmHg)at 4, 8 and 12 weeks
Response rate for antihypertensive therapyat 4, 8 and 12 weeks

Rate of patients with supine blood pressure normalized (SBP \<140 mmHg and DBP \<90 mmHg) or decrease of SBP ≥20 mmHg and/or decrease of DBP ≥10 mmHg from baseline

Trial Locations

Locations (15)

Regional state budget health care institution "Altai Regional Cardiological dispensary" 46 Malakhova St.

🇷🇺

Barnaul, Altai Region, Russian Federation

Problems of Cardiovascular Diseases" 6 Sosnovy Bulvar St.

🇷🇺

Kemerovo, Russian Federation

Autonomous non-profit organization "Medical Center "Alliance" 12 Molodezhnaya St., 12

🇷🇺

Kirovsk, Russian Federation

State budgetary healthcare institution of city of Moscow "City polyclinic #2 of Healthcare Department of city of Moscow" 12 Fruktovaya St.

🇷🇺

Moscow, Russian Federation

Federal State Budgetary Institution ''Ourpatient clinic #5'' of the Administration of the President of the Russian Federation 14 Plyushchikha St.

🇷🇺

Moscow, Russian Federation

St. Petersburg State Budgetary Healthcare Institution "The city hospital No.38. named after N.A. Semashko" 7/2 letter A Gospitalnaya Str., Pushkin

🇷🇺

Saint Pertersburg, Russian Federation

Pavlov First Saint Petersburg State Medical University L'va Tolstogo str. 6-8

🇷🇺

Saint Pertersburg, Russian Federation

LLC "Medicinskie tekhnologii", Nevzorova street, 6/191025, Saint-Petersburg, Vosstania street, 8 lit A

🇷🇺

Saint Petersburg, Russian Federation

LLC "Strategicheskie Medicinskie Sistemy", Nevzorova street, 6

🇷🇺

Saint Petersburg, Russian Federation

Saint-Petersburg State Budgetary Healthcare Institution "City outpatient clinic №109" 8 bld. 2 Oleko Dundicha

🇷🇺

Saint Petersburg, Russian Federation

Scroll for more (5 remaining)
Regional state budget health care institution "Altai Regional Cardiological dispensary" 46 Malakhova St.
🇷🇺Barnaul, Altai Region, Russian Federation

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.